Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers

Purpose: Anxiety is common among cancer patients and their family caregivers (FCs) and is associated with poorer outcomes. Recently, associations between inflammation and anxiety were identified. However, the relationship between variations in cytokine genes and anxiety warrants investigation. Therefore, phenotypic and genotypic characteristics associated with trait and state anxiety were evaluated in a sample of 167 oncology patients with breast, prostate, lung, or brain cancer and 85 of their FCs. Methods: Using multiple regression analyses, the associations between participants’ demographic and clinical characteristics as well as variations in cytokine genes and trait and state anxiety were evaluated. Results: In the bivariate analyses, a number of phenotypic characteristics were associated with both trait and state anxiety (e.g., age, functional status). However, some associations were specific only to trait anxiety (e.g., number of comorbid conditions) or state anxiety (e.g., participation with a FC). Variations in three cytokine genes (i.e., interleukin (IL) 1 beta, IL1 receptor 2 (IL1R2), nuclear factor kappa beta 2 (NFKB2)) were associated with trait anxiety, and variations in two genes (i.e., IL1R2, tumor necrosis factor alpha (TNFA)) were associated with state anxiety. Conclusions: These findings suggest that both trait and state anxiety need to be assessed in oncology patients and their FCs. Furthermore, variations in cytokine genes may contribute to higher levels of anxiety in oncology patients and their FCs

Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers

Purpose: Anxiety is common among cancer patients and their family caregivers (FCs) and is associated with poorer outcomes. Recently, associations between inflammation and anxiety were identified. However, the relationship between variations in cytokine genes and anxiety warrants investigation. Therefore, phenotypic and genotypic characteristics associated with trait and state anxiety were evaluated in a sample of 167 oncology patients with breast, prostate, lung, or brain cancer and 85 of their FCs. Methods: Using multiple regression analyses, the associations between participants’ demographic and clinical characteristics as well as variations in cytokine genes and trait and state anxiety were evaluated. Results: In the bivariate analyses, a number of phenotypic characteristics were associated with both trait and state anxiety (e.g., age, functional status). However, some associations were specific only to trait anxiety (e.g., number of comorbid conditions) or state anxiety (e.g., participation with a FC). Variations in three cytokine genes (i.e., interleukin (IL) 1 beta, IL1 receptor 2 (IL1R2), nuclear factor kappa beta 2 (NFKB2)) were associated with trait anxiety, and variations in two genes (i.e., IL1R2, tumor necrosis factor alpha (TNFA)) were associated with state anxiety. Conclusions: These findings suggest that both trait and state anxiety need to be assessed in oncology patients and their FCs. Furthermore, variations in cytokine genes may contribute to higher levels of anxiety in oncology patients and their FCs

A systematic review of symptom assessment scales in children with cancer

<p>Abstract</p> <p>Background</p> <p>The objective was to describe symptom assessment scales that have been used in children with cancer.</p> <p>Methods</p> <p>We conducted electronic searches of OVID Medline and EMBASE in order to identify all symptom assessment scales that have been used in pediatric cancer. Two reviewers abstracted information from each identified study. Data collected included study demographics and information related to the instrument and children enrolled. We also collected information about the purpose of instrument administration and whether treatment was altered as a result of this information.</p> <p>Results</p> <p>Fourteen studies were identified which evaluated eight different symptom assessment scales. Eight studies used child self-report and all studies included children on active treatment for cancer although 4 studies also included children following completion of treatment. The most common purpose of instrument administration was to measure the prevalence of symptom burden (n = 8). None of the 14 studies used the scale to screen for symptoms and none changed patient management on the basis of identified symptoms.</p> <p>Conclusions</p> <p>We failed to identify any symptom assessment scales that were used as a symptom screening tool. There is a need to develop such a tool for use in children with cancer.</p

Análise das medidas aerodinâmicas no português brasileiro por meio do Método Multiparamétrico de Avaliação Vocal Objetiva Assistida (EVA) Analysis of aerodynamic measures in Brazilian portuguese through Multiparameter Assessment Method Vocal Objective Assist (EVA)

OBJETIVO: definir medidas aerodinâmicas em falantes do português brasileiro, sem queixas vocais, obtidas pelo programa EVA. MÉTODO: participaram do estudo 20 homens e 20 mulheres, que tiveram suas vozes analisadas. RESULTADOS: os valores médios referentes à pressão subglótica para vozes femininas e masculinas foram, respectivamente: Pressão subglótica= 5,84 hPa e 6,7 hPa, média da intensidade= 79,21 dB e 81,7 dB, média do fluxo oral= 0,09 dm³/s e 0,16 dm³/s, eficiência glótica= 13,87 dB/hPa e 12,78 dB/hPa, eficiência laríngea= 188,08 dB/(hPa.dm³/s) e 97,11 dB/(hPa.dm³/s), resistência laríngea= 96,26 hPa/(dm³/s) e 52,64 hPa/(dm³/s), média da frequência fundamental (F0)= 208,28 Hz e 136,56 Hz e pico da pressão do fluxo oral= 0,093 e 0,098. Houve diferença estatisticamente significante em relação ao gênero para as medidas de média de intensidade, eficiência laríngea, resistência laríngea e média da frequência fundamental. Os valores médios referentes ao fluxo oral para vozes femininas e masculinas foram respectivamente: Pressão subglótica= 6,05 hPa e 6,6 hPa, média da intensidade= 65,50 dB e 66,3 dB, média do fluxo oral= 0,10 dm³/s e 0,13 dm³/s, eficiência glótica= 11,12 dB/hPa e 11,77 dB/hPa, eficiência laríngea= 144,83 dB/(hPa.dm³/s) e 97,89 dB/(hPa.dm³/s), resistência laríngea= 78,98 hPa/(dm³/s) e 61,81 hPa/(dm³/s), média da F0= 222,52 Hz e 139,20 Hz e pico da pressão do fluxo oral= 0,047 e 0,053. CONCLUSÃO: o EVA é um programa ainda novo no Brasil, e a análise de medidas aerodinâmicas, em falantes do português brasileiro, permite a obtenção de valores de referência, possibilitando assim comparações com estudos futuros.<br>PURPOSE: to define aerodynamic measures in Brazilian Portuguese speakers without voice complaints, obtained by the EVA program. METHOD: the study included 20 men and 20 women who had their voices analyzed. RESULTS: the mean values with subglottic pressure for female and male voices were: Subglottic pressure = 5.84 hPa and 6.7 hPa; average intensity = 79.21dB and 81.7dB; oral mean flow = 0.09 dm3/s and 0.16 dm3/s; glottic efficiency = 13.87dB/hPa and 12.78 dB/hPa; laryngeal efficiency = 188.08 dB/(hPa.dm3/s) and 97.11dB/(hPa.dm3/s); laryngeal resistance = 96.26 hPa/(dm3/s) and 52.64 hPa/(dm3/s); mean fundamental frequency (F0) = 208.28 Hz and 136.56 Hz and peak mouth pressure flow = 0.093 and 0.098. There was a statistically significant difference in relation to gender for the measures of average intensity, efficiency, larynx, laryngeal resistance and mean fundamental frequency. The average flow for the oral female and male voices were: subglottic pressure = 6.05 hPa and 6.6 hPa; average intensity = 65.50 dB and 66.3 dB; oral mean flow = 0, 10 dm3/s and 0.13 dm3/s; glottic efficiency = 11.12 dB/hPa and 11.77 dB/hPa; laryngeal efficiency = 144.83 dB/( hPa.dm3/s) and 97.89 dB/( hPa.dm3/s); laryngeal resistance = 78.98 hPa/(dm3/s) and 61.81 hPa/( dm3/s); average F0 = 222.52 Hz and 139.20 Hz and peak pressure oral flow = 0.047 and 0.053. CONCLUSION: EVA is a new program in Brazil, and analysing the aerodynamic measures in Brazilian Portuguese speakers, allows us to obtain reference values, thus allowing comparisons with future studies